Results for tag: "Olmesartan"

The Olmesartan market is a segment of the Cardiovascular Drugs market. Olmesartan is an angiotensin II receptor antagonist used to treat hypertension and congestive heart failure. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. Olmesartan is available in both generic and branded forms. The Olmesartan market is highly competitive, with a number of major players offering a range of products. Companies in the market include Daiichi Sankyo, Mylan, Teva Pharmaceuticals, Lupin Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more